Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.

Maria Maddalena SirufoEnrica Maria BassinoFrancesca De PietroLia GinaldiMassimo De Martinis

Published in: International journal of immunopathology and pharmacology (2022)

Although there are no certainties on the mechanism of action of omalizumab in CSU, the noticeable difference in response between males and females lead us to suppose a role of the hormonal balance both on the pathogenesis of the CSU and on the efficacy of OmAb.

Keyphrases

type diabetes
polycystic ovary syndrome
metabolic syndrome
adipose tissue
insulin resistance